Goldman Sachs’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $29.1M | Sell |
|
|||||
|
2023
Q1 | $29.7M | Sell |
|
|||||
|
2022
Q4 | $142M | Buy |
|
|||||
|
2022
Q3 | $33.7M | Buy |
|
|||||
|
2022
Q2 | $46.1M | Sell |
|
|||||
|
2022
Q1 | $55.8M | Buy |
|
|||||
|
2021
Q4 | $49.6M | Sell |
|
|||||
|
2021
Q3 | $46.6M | Buy |
|
|||||
|
2021
Q2 | $43.9M | Sell |
|
|||||
|
2021
Q1 | $68.7M | Sell |
|
|||||
|
2020
Q4 | $64M | Sell |
|
|||||
|
2020
Q3 | $74.2M | Buy |
|
|||||
|
2020
Q2 | $49.4M | Sell |
|
|||||
|
2020
Q1 | $51.4M | Sell |
|
|||||
|
2019
Q4 | $89M | Sell |
|
|||||
|
2019
Q3 | $84.5M | Sell |
|
|||||
|
2019
Q2 | $93.5M | Sell |
|
|||||
|
2019
Q1 | $101M | Sell |
|
|||||
|
2018
Q4 | $91.8M | Sell |
|
|||||
|
2018
Q3 | $130M | Buy |
|
|||||
|
2018
Q2 | $100M | Buy |
|
|||||
|
2018
Q1 | $39.9M | Buy |
|
|||||
|
2017
Q4 | $18.5M | Sell |
|
|||||
|
2017
Q3 | $30.3M | Buy |
|
|||||
|
2017
Q2 | $17.6M | Sell |
|
|||||
|
2017
Q1 | $27.4M | Buy |
|
|||||
|
2016
Q4 | $9.48M | Sell |
|
|||||
|
2016
Q3 | $15.2M | Buy |
|
|||||
|
2016
Q2 | $9.1M | Buy |
|
|||||
|
2016
Q1 | $2.91M | Buy |
|
|||||
|
2015
Q4 | $674K | Sell |
|
|||||
|
2015
Q3 | $2.25M | Buy |
|
|||||
|
2015
Q2 | $1.54M | Buy |
|
|||||
|
2015
Q1 | $760K | Sell |
|
|||||
|
2014
Q4 | $1.95M | Buy |
|